ReviewDisease models & mechanisms2025
Emerging toxicological awareness of per- and polyfluoroalkyl substances: the rising concern over 'forever chemicals'.
Review in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Review
- Immune insights and toxicity testing: an interview with Jeff Yoder.Disease models & mechanisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) are often called 'forever chemicals'. This colloquialism reflects that many PFAS are recalcitrant to environmental and metabolic degradation, leading to long environmental and biological half-lives. This persistence, a concerning characteristic of these synthetic substances, is also a reason they are used in many products and processes. Most PFAS have physical-chemical properties that enable them to withstand extreme conditions and make them useful for a range of applications, including as surfactants or coatings that confer oil-, stain- and water-repellency. This combination of persistence and wide use has resulted in extensive environmental contamination and the presence of PFAS in living organisms, leading to use restrictions. Increasing evidence of health effects has also led to implementation of health protective guidelines. In the United States, federal regulations enacted in 2024 limit levels of six PFAS in drinking water; in the European Union, a proposed restriction would control use, import and production of the vast majority of PFAS. This Perspective article summarizes how knowledge of toxicological hazards and health-related costs of PFAS has progressed in recent years, leading to actions to restrict PFAS uses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.